# Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)

> **NCT05854927** · — · RECRUITING · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 133 (estimated)

## Conditions studied

- Giant Cell Arteritis

## Interventions

- **DIAGNOSTIC_TEST:** 3D T1 MRI sequences injected with fat saturation and black blood

## Key facts

- **NCT ID:** NCT05854927
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-10
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 133 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854927, "Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05854927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*